Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on drug development, with no approved products. Its lead candidate, Aramchol, was historically developed for NASH and liver fibrosis treatment and is now being advanced for oncological indications. The company has generated limited revenue through a licensing agreement with Samil Pharm. Co., Ltd., and is actively seeking to expand its pipeline targeting cardiometabolic indications.
Look up GLMD using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on GLMD, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/GLMD (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.